Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes G Ehx, JD Larouche, C Durette, JP Laverdure, L Hesnard, K Vincent, ... Immunity 54 (4), 737-752. e10, 2021 | 75 | 2021 |
The Origin and Immune Recognition of Tumor-Specific Antigens A Apavaloaei, MP Hardy, P Thibault, C Perreault Cancers 12 (9), 2607, 2020 | 47 | 2020 |
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin I Hafstrand, EC Sayitoglu, A Apavaloaei, BJ Josey, R Sun, X Han, ... Proceedings of the National Academy of Sciences 116 (11), 2019 | 44 | 2019 |
PSMB11 orchestrates the development of CD4 and CD8 thymocytes via regulation of gene expression in cortical thymic epithelial cells A Apavaloaei, S Brochu, M Dong, A Rouette, MP Hardy, G Villafano, ... The Journal of Immunology 202 (3), 966-978, 2019 | 29 | 2019 |
Induced pluripotent stem cells display a distinct set of MHC I-associated peptides shared by human cancers A Apavaloaei, L Hesnard, MP Hardy, B Benabdallah, G Ehx, C Thériault, ... Cell Reports 40 (7), 111241, 2022 | 11 | 2022 |
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens MVR Cuevas, MP Hardy, JD Larouche, A Apavaloaei, E Kina, K Vincent, ... Genome Biology 24 (1), 188, 2023 | 7 | 2023 |
Breast cancer immunopeptidomes contain numerous shared tumor antigens E Kina, JP Laverdure, C Durette, J Lanoix, M Courcelles, Q Zhao, ... The Journal of Clinical Investigation 134 (1), 2024 | 4 | 2024 |
PSMB11 regulates gene expression in cortical thymic epithelial cells A Apavaloaei, JP Laverdure, C Perreault Cell Reports 36 (10), 109546, 2021 | 4 | 2021 |
BamQuery: a proteogenomic tool for the genome-wide exploration of the immunopeptidome MV Ruiz Cuevas, MP Hardy, JD Larouche, A Apavaloaei, E Kina, ... bioRxiv, 2022.10. 07.510944, 2022 | 1 | 2022 |
Psmb11 molds the transcriptome of cortical TECs and CD8 thymocytes A Apavaloaei, A Rouette, S Brochu, C Perreault The Journal of Immunology 198 (1_Supplement), 202.14-202.14, 2017 | 1 | 2017 |
Exploring the landscape of actionable HLA I-associated tumor antigens across cancers A Apavaloaei | | 2023 |
Immunotargeting of a recurrent AML-specific neoantigen A Apavaloaei, C Perreault Nature Cancer 4 (10), 1403-1405, 2023 | | 2023 |
Unmutated tumor antigens are abundant and contribute to tumor control in melanoma A Apavaloaei, Q Zhao, L Hesnard, K Vincent, MP Hardy, C Durette, ... Cancer Research 83 (7_Supplement), 2993-2993, 2023 | | 2023 |
BamQuery: a new proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens MVR Cuevas, MP Hardy, JD Larouche, A Apavaloaei, E Kina, K Vincent, ... Cancer Research 83 (7_Supplement), 2987-2987, 2023 | | 2023 |
Novel tumor-specific antigens for cancer stem cells and uses thereof C Perreault, P Thibault, MP HARDY, A APAVALOAEI | | 2023 |
BamQuery: a proteogenomic tool for the genome-wide exploration of the immunopeptidome MVR Cuevas, MP Hardy, JD Larouche, A Apavaloaei, E Kina, K Vincent, ... | | 2022 |
37P Breast cancer immunopeptidomes reveal a large number of targetable tumor antigens E Kina, JP Laverdure, C Durette, J Lanoix, Q Zhao, A Apavaloaei, ... Annals of Oncology 33, S558, 2022 | | 2022 |
BamQuery: A new proteogenomic tool to explore the immunopeptidome and validate tumor‐specific antigens MV Ruiz, A Apavaloaei, Q Zhao, MP Hardy, S Lemieux, C Perreault, ... European Journal of Immunology 51 (S1), 2021 | | 2021 |
Abstract B16: Identification of tumor-specific antigens shared by induced pluripotent stem cells A Apavaloaei, MP Hardy, JD Larouche, Q Zhao, K Vincent, JP Laverdure, ... Cancer Immunology Research 8 (3_Supplement), B16-B16, 2020 | | 2020 |
Examining how PSMB11 orchestrates T cell development A Apavaloaei | | 2018 |